Sign In

Phil Kearney

Retired at Merck

Dr. Phil Kearney is a seasoned professional with a diverse educational background and extensive experience in the field of Genetics and Biochemistry.

He holds a PhD in Genetics from Monash University, a BSc Hons in Biochemistry from the University of Sydney, and an MBA from the Australian Graduate School of Management. Additionally, he has taught as an Associate Professor at UNSW, showcasing his commitment to academia and knowledge sharing.

With a rich history of roles in various prestigious organizations, Dr. Kearney has made significant contributions to the healthcare and pharmaceutical industry. He has served as the Chief Executive Officer at both Amaroq Therapeutics and Axelia Oncology, demonstrating his leadership skills and strategic acumen.

Prior to these roles, Dr. Kearney had a successful career at Merck, where he held key positions such as Director External Licensing and Director Biology. His experience at Santaris Pharma, Active Biotech Research AB, and St Vincent's Hospital further solidify his expertise in pharmacology, oncology, and research management.

Currently, Dr. Phil Kearney is involved with Amaroq Therapeutics as a Non-Executive Director and Scientific Advisory Board member, bringing his wealth of knowledge and industry insights to the organization.

His background in academia, coupled with his extensive experience in leadership and research, make Dr. Kearney a valuable asset to the scientific community and the pharmaceutical sector.

Phil Kearney
Add to my network

Location

Australia